A living thick nanofibrous implant bifunctionalized with active growth factor and stem cells for bone regeneration

Eap, S. ; Keller, L. ; Schiav, J. ; Huck, O. ; Jacomine, L. ; Fioretti, F. ; Gauthier, C. ; Sebastian, V. (Universidad de Zaragoza) ; Schwinté, P. ; Benkirane-Jessel, N.

Resumen: New-generation implants focus on robust, durable, and rapid tissue regeneration to shorten recovery times and decrease risks of postoperative complications for patients. Herein, we describe a new-generation thick nanofibrous implant functionalized with active containers of growth factors and stem cells for regenerative nanomedicine. A thick electrospun poly(e- caprolactone) nanofibrous implant (from 700 µm to 1 cm thick) was functionalized with chitosan and bone morphogenetic protein BMP-7 as growth factor using layer-by-layer technology, producing fish scale-like chitosan/BMP-7 nanoreservoirs. This extracellular matrix-mimicking scaffold enabled in vitro colonization and bone regeneration by human primary osteoblasts, as shown by expression of osteocalcin, osteopontin, and bone sialoprotein (BSPII), 21 days after seeding. In vivo implantation in mouse calvaria defects showed significantly more newly mineralized extracellular matrix in the functionalized implant compared to a bare scaffold after 30 days’ implantation, as shown by histological scanning electron microscopy/energy dispersive X-ray microscopy study and calcein injection. We have as well bifunctionalized our BMP-7 therapeutic implant by adding human mesenchymal stem cells (hMSCs). The activity of this BMP-7-functionalized implant was again further enhanced by the addition of hMSCs to the implant (living materials), in vivo, as demonstrated by the analysis of new bone formation and calcification after 30 days’ implantation in mice with calvaria defects. Therefore, implants functionalized with BMP-7 nanocontainers associated with hMSCs can act as an accelerator of in vivo bone mineralization and regeneration.

Idioma: Inglés

DOI: 10.2147/IJN.S72670

Año: 2015

Publicado en: International Journal of Nanomedicine 10 (2015), 1061-1075
ISSN: 1176-9114

Factor impacto JCR: 4.32 (2015)

Categ. JCR: PHARMACOLOGY & PHARMACY rank: 40 / 255 = 0.157 (2015) - Q1 - T1
Categ. JCR: NANOSCIENCE & NANOTECHNOLOGY rank: 26 / 83 = 0.313 (2015) - Q2 - T1

Factor impacto SCIMAGO: 1.323 - Bioengineering (Q1) - Biomaterials (Q1) - Biophysics (Q1) - Organic Chemistry (Q1) - Medicine (miscellaneous) (Q1) - Nanoscience and Nanotechnology (Q1) - Drug Discovery (Q1)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)